[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI101622B1 - Menetelmä terapeuttisesti aktiivisten N-(4-piperidyyli)(dihydrobentsofuraani)karboksamidi- tai N-(4-piperidyyli)(dihydro-2H-bentsopyraani)karboksamidijohdannaisten valmistamiseksi ja välituote - Google Patents

Menetelmä terapeuttisesti aktiivisten N-(4-piperidyyli)(dihydrobentsofuraani)karboksamidi- tai N-(4-piperidyyli)(dihydro-2H-bentsopyraani)karboksamidijohdannaisten valmistamiseksi ja välituote

Info

Publication number
FI101622B1
FI101622B1 FI911096A FI911096A FI101622B1 FI 101622 B1 FI101622 B1 FI 101622B1 FI 911096 A FI911096 A FI 911096A FI 911096 A FI911096 A FI 911096A FI 101622 B1 FI101622 B1 FI 101622B1
Authority
FI
Finland
Prior art keywords
aryl
alkyl
piperidyl
alk
cycloalkyl
Prior art date
Application number
FI911096A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI911096A (fi
FI911096A0 (fi
FI101622B (fi
Inventor
Georges Henri Paul Van Daele
Jean-Paul Rene Marie Bosmans
Michel Anna Jozef De Cleyn
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI911096A0 publication Critical patent/FI911096A0/fi
Publication of FI911096A publication Critical patent/FI911096A/fi
Application granted granted Critical
Publication of FI101622B publication Critical patent/FI101622B/fi
Publication of FI101622B1 publication Critical patent/FI101622B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Pyrane Compounds (AREA)
FI911096A 1990-03-06 1991-03-05 Menetelmä terapeuttisesti aktiivisten N-(4-piperidyyli)(dihydrobentsofuraani)karboksamidi- tai N-(4-piperidyyli)(dihydro-2H-bentsopyraani)karboksamidijohdannaisten valmistamiseksi ja välituote FI101622B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909005014A GB9005014D0 (en) 1990-03-06 1990-03-06 N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
GB9005014 1990-03-06

Publications (4)

Publication Number Publication Date
FI911096A0 FI911096A0 (fi) 1991-03-05
FI911096A FI911096A (fi) 1991-09-07
FI101622B FI101622B (fi) 1998-07-31
FI101622B1 true FI101622B1 (fi) 1998-07-31

Family

ID=10672103

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911096A FI101622B1 (fi) 1990-03-06 1991-03-05 Menetelmä terapeuttisesti aktiivisten N-(4-piperidyyli)(dihydrobentsofuraani)karboksamidi- tai N-(4-piperidyyli)(dihydro-2H-bentsopyraani)karboksamidijohdannaisten valmistamiseksi ja välituote

Country Status (39)

Country Link
US (2) US5185335A (sh)
EP (1) EP0445862B1 (sh)
JP (1) JP2601566B2 (sh)
KR (1) KR0177521B1 (sh)
CN (1) CN1038936C (sh)
AT (1) ATE191912T1 (sh)
AU (1) AU636012B2 (sh)
BG (1) BG60381B1 (sh)
CA (1) CA2037575C (sh)
CY (1) CY2235B1 (sh)
CZ (1) CZ286617B6 (sh)
DE (1) DE69132119T2 (sh)
DK (1) DK0445862T3 (sh)
ES (1) ES2147175T3 (sh)
FI (1) FI101622B1 (sh)
GB (1) GB9005014D0 (sh)
GR (1) GR3033461T3 (sh)
HK (1) HK1010727A1 (sh)
HR (1) HRP930483B1 (sh)
HU (2) HU221627B1 (sh)
IE (1) IE910710A1 (sh)
IL (1) IL97018A (sh)
LT (1) LT3708B (sh)
LV (1) LV10085B (sh)
MA (1) MA22076A1 (sh)
MY (1) MY108831A (sh)
NO (1) NO177424C (sh)
NZ (1) NZ237189A (sh)
PL (6) PL168384B1 (sh)
PT (1) PT96937B (sh)
RU (1) RU2070884C1 (sh)
SG (1) SG47482A1 (sh)
SI (1) SI9110396B (sh)
SK (2) SK282407B6 (sh)
TN (1) TNSN91010A1 (sh)
UA (1) UA25969A1 (sh)
YU (1) YU48854B (sh)
ZA (1) ZA911611B (sh)
ZW (1) ZW2391A1 (sh)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674849B1 (fr) * 1991-04-02 1994-12-23 Logeais Labor Jacques Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
EP0604494B1 (en) * 1991-09-12 1999-07-28 Smithkline Beecham Plc 5-ht4 receptor antagonists
AU667874B2 (en) * 1992-02-06 1996-04-18 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
GB9219163D0 (en) * 1992-09-10 1992-10-28 Smithkline Beecham Plc Pharmaceuticals
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
JPH08502273A (ja) * 1992-10-13 1996-03-12 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ▲下４▼レセプターアンタゴニスト用複素環式エステルまたはアミド
TW294595B (sh) * 1992-11-20 1997-01-01 Janssen Pharmaceutica Nv
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
US5739135A (en) * 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
JPH0820586A (ja) 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd １−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
GB9418326D0 (en) * 1994-09-12 1994-11-02 Lilly Industries Ltd Pharmaceutical compounds
JPH0873463A (ja) 1994-07-05 1996-03-19 Sanwa Kagaku Kenkyusho Co Ltd ベンゾピランカルボキサミド誘導体、その塩及び製法並びに用途
ATE187453T1 (de) * 1994-09-27 1999-12-15 Janssen Pharmaceutica Nv N-substituierte piperidinyl bicyclische benzoatderivate
WO1996010026A1 (en) * 1994-09-27 1996-04-04 Janssen Pharmaceutica N.V. Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
US6096763A (en) * 1995-02-23 2000-08-01 Merck & Co., Inc. α1a adrenergic receptor antagonists
TW360653B (en) * 1995-03-01 1999-06-11 Janssen Pharmaceutica Nv A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
GB9507882D0 (en) * 1995-04-18 1995-05-31 Pharmacia Spa Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
TW548103B (en) * 1997-07-11 2003-08-21 Janssen Pharmaceutica Nv Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
TWI242004B (en) 1998-04-28 2005-10-21 Dainippon Pharmaceutical Co 1-(1-substituted-4-piperidinyl)methyl-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
JP2002514643A (ja) * 1998-05-14 2002-05-21 エギシュ ヂョヂセルヂャール エルテー ベンゾフラン誘導体、それを含有する製薬学的な組成物及びその活性成分の製造方法。
EP1112270B1 (en) * 1998-09-10 2007-03-21 F. Hoffmann-La Roche Ag Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
CA2352278A1 (en) * 1998-11-23 2000-06-02 Janssen Pharmaceutica, N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
JO2181B1 (en) 1999-04-29 2003-04-23 شركة جانسين فارماسوتيكا ان. في Procalopride solution is taken by mouth
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
GB0011838D0 (en) * 2000-05-17 2000-07-05 Astrazeneca Ab Chemical compounds
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
RU2301806C2 (ru) * 2002-01-16 2007-06-27 Янссен Фармацевтика Н.В. Прукалоприд-n-оксид
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
DE10349113A1 (de) * 2003-10-17 2005-05-12 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Aminocrotonylverbindungen
GB0525661D0 (en) * 2005-12-16 2006-01-25 Glaxo Group Ltd Novel compounds
LT3091011T (lt) * 2006-04-07 2018-04-10 Vertex Pharmaceuticals Incorporated Atp surišančios kasetės transporterių moduliatoriai
CN102477002B (zh) * 2010-11-26 2015-04-15 苏州凯达生物医药技术有限公司 3-氨基-2,2-双甲基丙酰胺的制备方法
KR101671348B1 (ko) 2011-02-25 2016-11-01 주식회사유한양행 다이아미노피리미딘 유도체 및 그의 제조방법
GB201103397D0 (sh) * 2011-02-28 2011-04-13 Shire Movetis N V
KR101256908B1 (ko) 2011-04-28 2013-04-23 (주)에이치비메디컬스 주름제거용 충전체
CN102295594B (zh) * 2011-07-12 2016-01-20 上海医药工业研究院 4-n-取代-1-(3-甲氧基丙基)-4-哌啶胺类化合物及制备和应用
US20130045988A1 (en) 2011-08-18 2013-02-21 Shire Ag Combination therapy
KR101657616B1 (ko) 2013-05-24 2016-09-19 주식회사유한양행 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
WO2017137910A1 (en) 2016-02-11 2017-08-17 Symed Labs Limited Processes for the preparation of highly pure prucalopride succinate and its intermediates
CN110963999B (zh) * 2019-11-27 2021-05-11 广东东阳光药业有限公司 2,3-二氢苯并呋喃酰胺衍生物及其用途

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186135A (en) * 1976-08-04 1980-01-29 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
FR2396757A2 (fr) * 1977-07-08 1979-02-02 Ile De France Nouveaux 2,3-alkylene bis (oxy) benzamides substitues, leurs derives et leurs procedes de preparation
FR2493848B2 (fr) * 1980-11-07 1986-05-16 Delalande Sa Nouveaux derives des nor-tropane et granatane, leur procede de preparation et leur application en therapeutique
EP0069481A1 (en) * 1981-06-17 1983-01-12 Beecham Group Plc Azabicycloalkyl benzamides, process for their preparation and pharmaceutical compositions containing them
EP0068700A1 (en) * 1981-06-29 1983-01-05 Beecham Group Plc Azobicycloalkylbenzamides, process for their preparation and pharmaceutical compositions containing them
CA1183847A (en) 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
NZ203861A (en) * 1982-04-14 1986-07-11 Beecham Group Plc Bicyclic heterocyclic compounds and pharmaceutical compositions containing such
US4525356A (en) * 1982-11-02 1985-06-25 Hokuriku Pharmaceutical Co., Ltd. N-substituted flavone-8-carboxamides
WO1984003281A1 (en) * 1983-02-19 1984-08-30 Beecham Group Plc Azabicycloalkyl benzamide and anilide derivatives
JPS59186969A (ja) * 1983-04-08 1984-10-23 Yoshitomi Pharmaceut Ind Ltd ベンゾフラン−およびベンゾピランカルボキサミド誘導体
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
CA1297877C (en) * 1983-12-22 1992-03-24 Daniel Lednicer Benzofurancarboxamides useful as antiemetic or antipsychotic agents
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
GB8519707D0 (en) * 1985-08-06 1985-09-11 Fordonal Sa Chemical compounds
GB8527052D0 (en) * 1985-11-02 1985-12-04 Beecham Group Plc Compounds
FR2593504B1 (fr) 1986-01-30 1988-12-09 Ile De France Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
US4906643A (en) * 1987-07-17 1990-03-06 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides as gastrointestinal agents
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
US5130312A (en) * 1987-07-17 1992-07-14 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides
GB8718346D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa Substituted benzamides
ZA886585B (en) * 1987-09-08 1990-05-30 Lilly Co Eli Specific 5-ht,antagonists
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US4975439A (en) * 1987-09-25 1990-12-04 Janssen Pharmaceutical N.V. Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5041454A (en) * 1987-09-25 1991-08-20 Janssen Pharmaceutica N.V. Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US4863921A (en) * 1988-04-27 1989-09-05 Rorer Pharmaceutical Corporation Dibenzofurancarboxamides and their pharmaceutical compositions and methods
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives

Also Published As

Publication number Publication date
AU636012B2 (en) 1993-04-08
CN1038936C (zh) 1998-07-01
HRP930483A2 (en) 1995-12-31
SG47482A1 (en) 1998-04-17
PL289323A1 (en) 1992-03-09
IL97018A0 (en) 1992-03-29
PT96937B (pt) 1998-07-31
IL97018A (en) 1995-11-27
ATE191912T1 (de) 2000-05-15
TNSN91010A1 (fr) 1992-10-25
JP2601566B2 (ja) 1997-04-16
YU39691A (sh) 1994-06-10
CS46091A3 (en) 1991-10-15
CY2235B1 (en) 2003-07-04
DK0445862T3 (da) 2000-09-04
NO910863L (no) 1991-09-09
FI911096A (fi) 1991-09-07
GR3033461T3 (en) 2000-09-29
BG60381B1 (bg) 1995-01-31
PL168356B1 (pl) 1996-02-29
SI9110396A (en) 1997-12-31
PT96937A (pt) 1991-10-31
DE69132119D1 (de) 2000-05-25
KR0177521B1 (ko) 1999-03-20
CN1054598A (zh) 1991-09-18
YU48854B (sh) 2002-06-19
GB9005014D0 (en) 1990-05-02
DE69132119T2 (de) 2000-12-21
ES2147175T3 (es) 2000-09-01
JPH04211685A (ja) 1992-08-03
US5185335A (en) 1993-02-09
LV10085A (lv) 1994-05-10
SK282407B6 (sk) 2002-01-07
CZ286617B6 (cs) 2000-05-17
HU211350A9 (en) 1995-11-28
PL168693B1 (pl) 1996-03-29
MY108831A (en) 1996-11-30
NZ237189A (en) 1992-11-25
HU221627B1 (hu) 2002-12-28
AU7207991A (en) 1991-09-12
SK282406B6 (sk) 2002-01-07
IE910710A1 (en) 1991-09-11
HUT60733A (en) 1992-10-28
EP0445862A3 (en) 1992-05-20
NO177424C (no) 1995-09-13
ZA911611B (en) 1992-11-25
RU2070884C1 (ru) 1996-12-27
CA2037575C (en) 2003-09-16
MA22076A1 (fr) 1991-10-01
PL169238B1 (pl) 1996-06-28
NO910863D0 (no) 1991-03-05
CA2037575A1 (en) 1991-09-07
PL168686B1 (pl) 1996-03-29
FI911096A0 (fi) 1991-03-05
EP0445862A2 (en) 1991-09-11
BG93979A (bg) 1993-12-24
LT3708B (en) 1996-02-26
NO177424B (no) 1995-06-06
SI9110396B (sl) 2000-06-30
LTIP846A (en) 1995-02-27
UA25969A1 (uk) 1999-02-26
FI101622B (fi) 1998-07-31
ZW2391A1 (en) 1992-09-07
LV10085B (en) 1995-02-20
PL168384B1 (en) 1996-02-29
PL168811B1 (pl) 1996-04-30
HU910706D0 (en) 1991-09-30
HRP930483B1 (en) 2001-04-30
HK1010727A1 (en) 1999-06-25
EP0445862B1 (en) 2000-04-19
KR910016744A (ko) 1991-11-05
US5262418A (en) 1993-11-16

Similar Documents

Publication Publication Date Title
FI101622B1 (fi) Menetelmä terapeuttisesti aktiivisten N-(4-piperidyyli)(dihydrobentsofuraani)karboksamidi- tai N-(4-piperidyyli)(dihydro-2H-bentsopyraani)karboksamidijohdannaisten valmistamiseksi ja välituote
MY117557A (en) 1-(1,2-disubstituted piperidinyl)-4- substituted piperidine derivatives
NO178067C (no) Analogifremgangsmåte til fremstilling av terapautisk aktive heterocykliske forbindelser
MY117803A (en) Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
MY121852A (en) 4-(aminoethyl)-piperidine benzamides for treating gastrointestinal disorders
NZ508910A (en) Di-substituted piperazine or piperidine derivatives useful as muscarinic antagonists
MY117680A (en) 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)- piperidine derivatives
NZ333513A (en) 1,4-di-substituted piperidines and medicaments useful as muscarinic antagonists
ATE72431T1 (de) 5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren.
BG104717A (en) Water soluble azoles as broad-spectrum antifungals
AR006754A1 (es) Derivados de quinoxalina utiles en terapia
MX9701165A (es) Triazolinonas sustituidas como agentes para la proteccion de plantas.
MY101878A (en) 1,3,4-thiadiazole

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: MOVETIS N.V.

Free format text: MOVETIS N.V.